Susanna Koski

2PUBLICATIONS
17CO-AUTHORS
Infant and child healthNanotoxicology, health and safety
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

Sort by Publication Date:
|Jan 30, 2025
A Phase 3B, Open-Label Study to Evaluate the Immunogenicity and Safety of the Quadrivalent Meningococcal Nimenrix® Vaccine When Given to Healthy Infants at 3 and 12 Months of Age.

Susanna Koski, Federico Martinon-Torres, Mika Rämet

|Nov 25, 2024
4CMenB Breadth of Immune Response, Immunogenicity, and Safety: Results From a Phase 3 Randomized, Controlled, Observer Blind Study in Adolescents and Young Adults.

Terry Nolan, Chiranjiwi Bhusal, Jiří Beran

Pageof 1

Frequent Collaborators

2 joint publications

Mika Rämet

1 joint publications

Benhur S Cetin

1 joint publications

Ener C Dinleyici

1 joint publications

Joanne M Langley

1 joint publications

Peter Silas

1 joint publications

Mary Tipton

1 joint publications

Maria Lattanzi

1 joint publications

Arnold Willemsen

1 joint publications

Federico Martinon-Torres

1 joint publications

Mark Cutler

Frequent Collaborators

2 joint publications

Mika Rämet

1 joint publications

Benhur S Cetin

1 joint publications

Ener C Dinleyici

1 joint publications

Joanne M Langley

JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us

Top Related Videos

Evaluating the Immune Response of a Nanoemulsion Adjuvant Vaccine Against Methicillin-Resistant <em>Staphylococcus aureus</em> (MRSA) Infection
07:32

Evaluating the Immune Response of a Nanoemulsion Adjuvant Vaccine Against Methicillin-Resistant <em>Staphylococcus aureus</em> (MRSA) Infection

Published on : Sep 01, 2023

1.8K
Rapid <em>In Vivo</em> Assessment of Adjuvant's Cytotoxic T Lymphocytes Generation Capabilities for Vaccine Development
09:03

Rapid <em>In Vivo</em> Assessment of Adjuvant's Cytotoxic T Lymphocytes Generation Capabilities for Vaccine Development

Published on : Jun 19, 2018

8.6K
See more related videos

Top Related Videos

Evaluating the Immune Response of a Nanoemulsion Adjuvant Vaccine Against Methicillin-Resistant <em>Staphylococcus aureus</em> (MRSA) Infection
07:32

Evaluating the Immune Response of a Nanoemulsion Adjuvant Vaccine Against Methicillin-Resistant <em>Staphylococcus aureus</em> (MRSA) Infection

Published on : Sep 01, 2023

1.8K
Rapid <em>In Vivo</em> Assessment of Adjuvant's Cytotoxic T Lymphocytes Generation Capabilities for Vaccine Development
09:03

Rapid <em>In Vivo</em> Assessment of Adjuvant's Cytotoxic T Lymphocytes Generation Capabilities for Vaccine Development

Published on : Jun 19, 2018

8.6K
See more related videos